T1	Measurement 0 24	Hemoglobin concentration
T2	Value 25 41	under 6.5 mmol/l
R1	Has_value Arg1:T1 Arg2:T2	
T3	Measurement 53 58	HBA1c
T4	Value 59 79	more than 108 mmol/l
R2	Has_value Arg1:T3 Arg2:T4	
T5	Condition 81 94	Non-compliant
T6	Procedure 100 113	blood-letting
T7	Non-query-able 81 94	Non-compliant
R3	AND Arg1:T5 Arg2:T6	
T8	Condition 126 140	infected ulcer
T9	Procedure 175 202	revascularization procedure
T10	Reference_point 210 222	affected leg
T11	Temporal 223 246	within the last 8 weeks
R4	Has_temporal Arg1:T9 Arg2:T11	
R5	Has_index Arg1:T9 Arg2:T10	
T12	Observation 150 157	planned
T13	Observation 165 172	has had
*	OR T12 T13
T14	Scope 150 172	planned for or has had
R6	Has_scope Arg1:T9 Arg2:T14	
T15	Condition 252 257	ulcer
T16	Procedure 268 275	treated
T17	Drug 281 295	growth factors
T18	Temporal 296 315	in the last 8 weeks
R7	Has_temporal Arg1:T16 Arg2:T18	
R8	AND Arg1:T15 Arg2:T16	
R9	AND Arg1:T16 Arg2:T17	
T19	Condition 328 353	deep venous insufficiency
T20	Condition 355 379	chronic venous leg ulcer
T21	Condition 383 400	stasis dermatitis
*	OR T20 T21 T19
T22	Scope 328 400	deep venous insufficiency, chronic venous leg ulcer or stasis dermatitis
T23	Observation 317 324	History
R10	Has_temporal Arg1:T22 Arg2:T23	
T24	Condition 402 416	Breast-feeding
T25	Person 417 422	women
T26	Condition 426 433	fertile
T27	Person 434 439	women
T28	Observation 444 496	agreeing to use an effective method of contraception
T29	Negation 440 443	not
R11	Has_negation Arg1:T28 Arg2:T29	
R12	AND Arg1:T25 Arg2:T24	
R13	AND Arg1:T27 Arg2:T26	
*	OR T25 T27
R14	Has_context Arg1:T27 Arg2:T28	
T30	Non-query-able 498 575	Participation in another clinical ulcer-healing study within the last 4 weeks
T31	Non-query-able 577 629	Patient has previously been randomized in this study
T32	Subjective_judgement 631 717	Judgement by the investigator that the patient is not able to participate in the study
T33	Non-query-able 631 717	Judgement by the investigator that the patient is not able to participate in the study
